PT3407910T - Recombinant modified vaccinia virus ankara (mva) equine encephalitis virus vaccine - Google Patents

Recombinant modified vaccinia virus ankara (mva) equine encephalitis virus vaccine

Info

Publication number
PT3407910T
PT3407910T PT177028271T PT17702827T PT3407910T PT 3407910 T PT3407910 T PT 3407910T PT 177028271 T PT177028271 T PT 177028271T PT 17702827 T PT17702827 T PT 17702827T PT 3407910 T PT3407910 T PT 3407910T
Authority
PT
Portugal
Prior art keywords
mva
equine encephalitis
modified vaccinia
recombinant modified
ankara
Prior art date
Application number
PT177028271T
Other languages
Portuguese (pt)
Original Assignee
Bavarian Nordic As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bavarian Nordic As filed Critical Bavarian Nordic As
Publication of PT3407910T publication Critical patent/PT3407910T/en

Links

PT177028271T 2016-08-19 2017-01-27 Recombinant modified vaccinia virus ankara (mva) equine encephalitis virus vaccine PT3407910T (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP16185012 2016-08-19

Publications (1)

Publication Number Publication Date
PT3407910T true PT3407910T (en) 2022-07-05

Family

ID=56787320

Family Applications (1)

Application Number Title Priority Date Filing Date
PT177028271T PT3407910T (en) 2016-08-19 2017-01-27 Recombinant modified vaccinia virus ankara (mva) equine encephalitis virus vaccine

Country Status (1)

Country Link
PT (1) PT3407910T (en)

Similar Documents

Publication Publication Date Title
IL290052A (en) Recombinant modified vaccinia virus ankara (mva) filovirus vaccine
HUE059343T2 (en) Recombinant modified vaccinia virus ankara (mva) equine encephalitis virus vaccine
HK1255847A1 (en) Vaccines against hepatitis b virus
PT3480307T (en) New genetically-modified vaccinia virus
HK1251459A1 (en) Use of inactivated nonreplicating modified vaccinia virus ankara (mva)as monoimmunotherapy or in combination with immune checkpoint blocking agents for solid tumors
SG11201900439XA (en) Recombinant vaccinia virus and use thereof
EP3148566C0 (en) Synthetic long peptides (slp) for therapeutic vaccination against hepatitis b virus infection
ZA201801091B (en) Recombinant orf virus vector
IL254698A0 (en) Recombinant mumps virus jeryl lynn 2 based vaccine
SG11201808268UA (en) Recombinant hansenula-based high dosage hepatitis b vaccine
HK1251924A1 (en) Foxm1-derived peptide, and vaccine including same
PT3407910T (en) Recombinant modified vaccinia virus ankara (mva) equine encephalitis virus vaccine
EP3211073A4 (en) Replicative vaccinia virus vector hiv vaccine
GB201615311D0 (en) Virus, Vaccine cures
IL258107A (en) Mphosph1-derived peptide, and vaccine including same
GB201706600D0 (en) Virus preparations
GB201702193D0 (en) Hepatitis E virus vaccine
GB201507529D0 (en) Virus preparations